Kalvista Pharmaceuticals Inc (KALV) PT Lowered to $50 at Needham & Company, Following Earnings
Tweet Send to a Friend
Needham & Company analyst Serge ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
